Published in Clin Microbiol Rev on July 01, 1998
Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J (2010) 1.17
Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease. J Immunol (2009) 1.07
Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol (2011) 1.05
Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin. Pediatr Cardiol (2007) 1.01
Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions. Clin Res Cardiol (2009) 0.81
Superantigen involvement and susceptibility factors in Kawasaki disease: profiles of TCR Vβ2+ T cells and HLA-DRB1, TNF-α and ITPKC genes among Filipino patients. Int J Mol Epidemiol Genet (2013) 0.81
The first case of Kawasaki disease in a 20-month old baby following immunization with rotavirus vaccine and hepatitis A vaccine in China: A case report. Hum Vaccin Immunother (2015) 0.78
Kawasaki syndrome hospitalizations and associated costs in the United States. Public Health Rep (2003) 0.76
Severe Kawasaki disease in a 3-month-old patient: a case report. BMC Res Notes (2013) 0.75
Infection control consequences - early Staphylococcal Scalded Skin Syndrome or Kawasaki Syndrome? GMS Krankenhhyg Interdiszip (2009) 0.75
Lumps, bumps and vasculitis. J R Soc Med (2009) 0.75
A new look at acquired heart diseases in a contemporary sub-Saharan African pediatric population: the case of Yaoundé, Cameroon. Cardiovasc Diagn Ther (2015) 0.75
Clinical and epidemiological characteristics of kawasaki disease. Jundishapur J Microbiol (2014) 0.75
Kawasaki disease: a review with emphasis on cardiovascular complications. Insights Imaging (2010) 0.75
Kawasaki Disease Presenting with Bloody Diarrhea and Acute Renal Failure: First Case. Pediatr Rep (2017) 0.75
Sociodemographic profile of children with Kawasaki disease in North India. Clin Rheumatol (2014) 0.75
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi (1967) 9.06
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation (1996) 7.29
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med (1991) 5.76
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (1993) 4.06
High-dose intravenous gammaglobulin for Kawasaki disease. Lancet (1984) 3.10
Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr (1996) 2.77
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Mucocutaneous lymph node syndrome in the United States. Am J Dis Child (1976) 2.52
Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol (1982) 2.22
Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol (1996) 2.18
Gamma globulin re-treatment in Kawasaki disease. J Pediatr (1993) 2.13
Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics (1979) 2.08
Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet (1992) 1.97
Kawasaki disease in families. Pediatrics (1989) 1.83
Management of Kawasaki disease in the British Isles. Arch Dis Child (1993) 1.79
Kawasaki disease in infants less than one year of age. J Pediatr (1995) 1.67
Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr (1997) 1.64
Endothelial dysfunction late after Kawasaki disease. Circulation (1996) 1.53
Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med (1981) 1.52
Elevated levels of immunoglobulin E in the acute febrile mucocutaneous lymph node syndrome. Pediatr Res (1976) 1.48
Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics (1977) 1.48
Incomplete Kawasaki disease with coronary artery involvement. J Pediatr (1987) 1.46
Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jpn Circ J (1979) 1.45
Kawasaki disease in Auckland, 1979-1988. N Z Med J (1990) 1.45
IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol (1997) 1.44
Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr (1992) 1.40
Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol (1985) 1.39
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr (1986) 1.34
Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child (1995) 1.34
Update of the epidemiology of Kawasaki disease in Japan--from the results of 1993-94 nationwide survey. J Epidemiol (1996) 1.33
TCR V beta family repertoire and T cell activation markers in Kawasaki disease. J Immunol (1994) 1.29
Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr (1986) 1.26
Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr (1992) 1.26
Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol (1982) 1.24
Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86. Lancet (1986) 1.23
Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics (1994) 1.23
Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol (1996) 1.20
An epidemic of Kawasaki syndrome in Hawaii. J Pediatr (1982) 1.19
Altered lipid profile after Kawasaki syndrome. Circulation (1991) 1.19
Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol (1990) 1.16
Regression of aneurysms in Kawasaki disease: a pathological study. J Pediatr (1982) 1.15
Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease. Circulation (1994) 1.14
Cardiac transplantation for Kawasaki disease. Pediatrics (1997) 1.13
Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr (1995) 1.10
Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med (1989) 1.10
Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg (1994) 1.10
Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. Circulation (1989) 1.09
Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child (1987) 1.09
Kawasaki disease: cardiac problems and management. Pediatr Rev (1988) 1.06
Kawasaki syndrome: association with the application of rug shampoo. Lancet (1982) 1.06
High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol (1997) 1.06
Clonal expansion of CD8+ T cells in Kawasaki disease. J Immunol (1997) 1.02
The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis (1995) 1.01
Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn Circ J (1979) 1.00
Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res (1994) 0.99
The search for the etiology of Kawasaki disease. Pediatr Infect Dis J (1987) 0.98
Epidemiology of infant Kawasaki disease with a report of the youngest neonatal case ever reported in Japan. Acta Paediatr (1996) 0.98
Thrombocytopenia: a risk factor for acute myocardial infarction during the acute phase of Kawasaki disease. Coron Artery Dis (1995) 0.94
Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Am J Cardiol (1987) 0.94
Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. Br Med J (Clin Res Ed) (1985) 0.94
Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome. Nature (1989) 0.92
Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms. Am J Cardiol (1986) 0.91
Peripheral gangrene associated with Kawasaki disease. Clin Infect Dis (1992) 0.91
Kawasaki disease in Finland in 1982-1992. Scand J Infect Dis (1993) 0.90
Valvular heart disease in Kawasaki syndrome: incidence and natural history. Am Heart J (1990) 0.90
Serum interferon concentrations and retroviral serology in Kawasaki syndrome. Pediatr Infect Dis J (1988) 0.89
A two-year survey of mucocutaneous lymph node syndrome in northeastern Italy. Epidemiological and clinical findings. Helv Paediatr Acta (1984) 0.86
Kawasaki syndrome and the eye. Pediatr Infect Dis J (1989) 0.84
Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease. J Am Coll Cardiol (1996) 0.84
Efficacies and risks of aspirin in the treatment of the Kawasaki disease. Prog Clin Biol Res (1987) 0.84
Mucocutaneous lymph node syndrome (Kawasaki disease): delayed aortic and mitral insufficiency secondary to active valvulitis. J Am Coll Cardiol (1986) 0.84
Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease). Ann Allergy (1987) 0.83
Determinants of low serum concentrations of salicylates in patients with Kawasaki disease. J Pediatr (1988) 0.82
Pathology of Kawasaki disease in the healed stage. Relationships between typical and atypical cases of Kawasaki disease. Acta Pathol Jpn (1986) 0.81
The role of T cells in Kawasaki disease. Crit Rev Immunol (1995) 0.80
Comparative safety and efficacy of two immune globulin products in Kawasaki disease. J Pediatr (1995) 0.80
Serum cholesterol levels during and after Kawasaki disease. J Pediatr (1991) 0.80
Outbreak of Kawasaki syndrome in Finland. Acta Paediatr Scand (1986) 0.80
Variation in coronary arterial dimension (distensible abnormality) after disappearing aneurysm in Kawasaki disease. Am Heart J (1987) 0.79
[Two-dimensional echocardiography of coronary artery in Kawasaki disease (MCLS): detection, changes in acute phase, and follow-up observation of the aneurysm (author's transl)]. J Cardiogr (1981) 0.79
Immunoglobulin allotypic markers in Kawasaki disease. J Pediatr (1993) 0.78
Lack of effect of gamma-globulin infusion on circulating immune complexes in patients with Kawasaki syndrome. Pediatr Infect Dis J (1988) 0.78
Immunoglobulin G subclasses in serum and circulating immune complexes in patients with Kawasaki syndrome. Pediatr Infect Dis J (1990) 0.78
Kawasaki disease: monitoring of circulating immune complexes. Eur J Pediatr (1988) 0.78
Severe mitral regurgitation due to coronary arteritis of mucocutaneous lymph node syndrome. A new surgical entity. J Thorac Cardiovasc Surg (1980) 0.76
Failure to confirm the presence of a retrovirus in cultured lymphocytes from patients with Kawasaki syndrome. Pediatr Res (1991) 0.76
Kawasaki syndrome. A case-control study during an outbreak in Maryland. Am J Dis Child (1985) 0.76
High levels of IgA-containing circulating immune complex and secretory IgA in Kawasaki disease. Microbiol Immunol (1987) 0.76
Kawasaki syndrome: a controlled study of an outbreak in Wisconsin. Am J Epidemiol (1986) 0.76
IVGG therapy in Kawasaki disease: mechanism(s) of action. Clin Immunol Immunopathol (1989) 0.76
Multiple outbreaks of Kawasaki syndrome--United States. MMWR Morb Mortal Wkly Rep (1985) 0.76
Atypical Kawasaki disease: an often missed diagnosis. Eur J Pediatr (1992) 0.76
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr (1991) 2.82
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Group C beta-hemolytic streptococcal infections in children: nine pediatric cases and review. Rev Infect Dis (1989) 2.09
Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J (1994) 1.99
Abandoning empirical antibiotics for febrile children. Lancet (1997) 1.75
Kawasaki disease in infants less than one year of age. J Pediatr (1995) 1.67
Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr (1997) 1.64
CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis (2001) 1.62
Optical immunoassay test for group A beta-hemolytic streptococcal pharyngitis. An office-based, multicenter investigation. JAMA (1997) 1.61
Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics (1999) 1.61
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr (1991) 1.60
IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis (2000) 1.58
Clinical aspects of acute rheumatic fever. J Rheumatol Suppl (1991) 1.57
Kawasaki syndrome. Rev Infect Dis (1988) 1.55
Kawasaki syndrome. Pediatr Clin North Am (1999) 1.53
Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy. J Pediatr (1988) 1.49
Evaluation of an ELISA for group A streptococcal antigen for diagnosis of pharyngitis. J Pediatr (1987) 1.47
Incomplete Kawasaki disease with coronary artery involvement. J Pediatr (1987) 1.46
IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol (1997) 1.44
The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med (1972) 1.35
Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics (1983) 1.33
Does Kawasaki disease have a retroviral aetiology? Lancet (1986) 1.26
Ewingella americana: recurrent pseudobacteremia from a persistent environmental reservoir. J Clin Microbiol (1987) 1.25
Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics (1994) 1.23
Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr (1985) 1.21
Neurocysticercosis among children in Chicago. Clin Infect Dis (1996) 1.21
Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J (1987) 1.19
Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control (2001) 1.18
Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol (2001) 1.16
Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies. J Infect Dis (1981) 1.16
Kawasaki disease in older children and adolescents. J Pediatr (2000) 1.15
Cardiac transplantation for Kawasaki disease. Pediatrics (1997) 1.13
Periorbital and orbital cellulitis in children. Pediatrics (1978) 1.13
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis. J Infect Dis (1986) 1.12
Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child (1987) 1.09
An unique presentation of sickle cell disease: pyogenic hepatic abscess. Pediatrics (1971) 1.08
Staphylococcus lugdunensis: an emerging cause of ventriculoperitoneal shunt infections. Pediatr Neurosurg (2001) 1.06
Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis (1997) 1.06
Transection of spinal cord. A rare obstetrical complication of cephalic delivery. Arch Dis Child (1971) 1.04
A nosocomial common source outbreak caused by Pseudomonas pickettii. Pediatr Infect Dis (1984) 1.04
Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatr Cardiol (2005) 1.03
The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis (1995) 1.01
Kawasaki disease. Am Fam Physician (1999) 0.99
Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res (1994) 0.99
Differences in antibody response to streptococcal antigens in children with rheumatic and non-rheumatic mitral valve disease. Circulation (1974) 0.99
The search for the etiology of Kawasaki disease. Pediatr Infect Dis J (1987) 0.98
Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr (1991) 0.98
Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections. J Pediatr (1983) 0.97
Streptococcal pharyngitis: the carrier state, definition, and management. Pediatr Ann (1998) 0.97
Pulmonary and cerebral mycetoma caused by Curvularia pallescens. J Pediatr (1977) 0.96
Multiple group B streptococcal infections in a premature infant: eradication of nasal colonization with rifampin. Am J Dis Child (1985) 0.96
Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res (1997) 0.95
Recent developments in Kawasaki disease. Curr Opin Infect Dis (2001) 0.94
Lung abscess in infants and children. Clin Pediatr (Phila) (1995) 0.93
Large outbreak of pertussis among young children in Chicago, 1993: investigation of potential contributing factors and estimation of vaccine effectiveness. Pediatr Infect Dis J (1996) 0.93
Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin Infect Dis (1996) 0.93
Tuberculosis-associated hemophagocytic syndrome in an infant. Pediatr Infect Dis J (2000) 0.93
Peripheral gangrene associated with Kawasaki disease. Clin Infect Dis (1992) 0.91
Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the young, the American Heart Association. Pediatr Infect Dis J (1989) 0.91
Once daily ceftriaxone for central nervous system infections and other serious pediatric infections. Pediatr Infect Dis (1986) 0.91
Complications of mastoiditis with special emphasis on venous sinus thrombosis. J Pediatr (1982) 0.90
Circulating cardiac troponin I levels in Kawasaki disease. Pediatr Cardiol (2001) 0.90
Generalized nonsuppurative myositis with staphylococcal septicemia. J Pediatr (1980) 0.90
A.H.A. committee report. Prevention of rheumatic fever. Circulation (1977) 0.89
Immunoconglutinin and complement studies in congenital nephrotic syndrome and nephritis of Henoch-Schönlein purpura in children. Arch Dis Child (1971) 0.89
Recent developments and controversies in Kawasaki disease. Minerva Pediatr (2004) 0.89
Treatment of Salmonella meningitis and brain abscess with the new cephalosporins: two case reports and a review of the literature. Pediatr Infect Dis J (1987) 0.89
Pulmonary paragonimiasis in Laotian refugee children. Pediatrics (1982) 0.89
Serum interferon concentrations and retroviral serology in Kawasaki syndrome. Pediatr Infect Dis J (1988) 0.89
Myocardial injury in children with respiratory syncytial virus infection. Pediatr Crit Care Med (2000) 0.88
Treatment of pediatric infections with amikacin as first-line aminoglycoside. Am J Med (1985) 0.87
Severe neonatal enteroviral hepatitis treated with pleconaril. Pediatr Infect Dis J (2001) 0.87
Staphylococcal osteomyelitis, sepsis, and pulmonary disease. Observations of 10 patients with combined osseous and pulmonary infections. Radiology (1975) 0.87
Pseudomonas stutzeri: an unusual cause of calcaneal Pseudomonas osteomyelitis. Pediatr Infect Dis J (1987) 0.86
The problem of maternal syphilis after serologic surveillance during pregnancy. Am J Obstet Gynecol (1973) 0.86
Kawasaki syndrome. Curr Probl Pediatr (1991) 0.86
Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis. J Pediatr (1990) 0.86
The changing spectrum of neonatal endocarditis. Clin Perinatol (1988) 0.85
Prevention of bacterial endocarditis: recommendations by the American Heart Association. J Am Dent Assoc (1997) 0.85
Bacterial and fungal colonization of endotracheal tubes in children: a prospective study. Crit Care Med (1992) 0.84
Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease. Pediatr Res (2001) 0.84
Mucocutaneous lymph node syndrome (Kawasaki disease): delayed aortic and mitral insufficiency secondary to active valvulitis. J Am Coll Cardiol (1986) 0.84
The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis. Clin Nephrol (1979) 0.84
The rise and fall (and rise?) of rheumatic fever. JAMA (1988) 0.83
Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children? Clin Infect Dis (1998) 0.83
Combination antibiotic therapy in pediatrics. Am J Med (1986) 0.83
Severe staphylococcal sepsis in adolescents. Pediatrics (1976) 0.83
Salmonella cholera-suis: a distinctive bacterial pathogen. J Pediatr (1981) 0.83
Coronary artery bypass grafting for Kawasaki disease. Pediatr Cardiol (2002) 0.82
Qualitative and quantitative aspects of the human antibody response to streptococcal group A carbohydrate. J Clin Invest (1974) 0.82
Plasmids of Ewingella americana: supplementary epidemiologic markers in an outbreak of pseudobacteremia. J Clin Microbiol (1987) 0.82
High-dose aspirin in Kawasaki disease. J Pediatr (1999) 0.82